Brett King

基本信息

浏览量：13

职业迁徙

个人简介

Dr. Brett King is Associate Professor of Dermatology, specializing in skin diseases recalcitrant to first-line therapies. He has pioneered the use of Janus kinase (JAK) inhibitors in cutaneous diseases, in particular for alopecia areata, vitiligo, atopic dermatitis, granuloma annulare, sarcoidosis, and erosive lichen planus, in addition to other disorders. He sees patients at Yale Dermatology-Middlebury.

研究兴趣

论文共 234 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Online Sourcing of Medications: the Patient Buying Medication from Online Pharmacies Abroad

Buket Beresford-Wylie, Matthew Harries,Brett King, Andrew Y Finlay,Leila Asfour

Clinical and experimental dermatology (2024)

引用0浏览0WOS引用

Efficacy and Safety of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, in Adolescent and Adult Patients with Alopecia Totalis and Alopecia Universalis

Natasha Mesinkovska,Brett King,Xingqi Zhang,Emma Guttman-Yassky,Nina Magnolo,Rodney Sinclair,Masato Mizuashi,Jerry Shapiro,Elena Peeva,Anindita Banerjee,Liza Takiya,Lori Ann Cox,Dalia Wajsbrot,Urs Kerkmann,Ernest Law,Robert Wolk,Gregor Schaefer

JOURNAL OF DERMATOLOGYno. 11 (2024): 1414-1424

引用0浏览0WOS引用

Patient-Reported Hair Loss and Its Impacts As Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: the ALLEGRO Phase 2b/3 Randomized Clinical Trial

Rodney Sinclair,Natasha Mesinkovska,Debanjali Mitra,Dalia Wajsbrot,Ernest H. Law,Robert Wolk,Brett King

American Journal of Clinical Dermatologypp.1-11, (2024)

引用0浏览0WOS引用

JAK Inhibitors As Immunomodulators

Danielle Peterson,William Damsky,Brett King

Immunomodulators and Biologics in Dermatologic Treatmentpp.57-71, (2024)

引用0浏览0引用

51436 Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata from 2 Randomized Clinical Trials over a Median of 2.3 Years and Up to 4 Years of Exposure

Brett King,Arash Mostaghimi, Yutaka Shimomura,Bianca Maria Piraccini, Ulrike Blume-Peytavi,Angelina Sontag,Yves Dutronc,Katrin Holzwarth,Jill Kolodsick, Xiaoyu Lu,Rodney Sinclair

Journal of the American Academy of Dermatologyno. 3 (2024): AB82

引用0浏览0引用

Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

Brett King,Jennifer Soung,Christos Tziotzios,Lidia Rudnicka,Pascal Joly,Melinda Gooderham,Rodney Sinclair,Natasha A. Mesinkovska,Carle Paul, Yankun Gong,Susan D. Anway,Helen Tran,Robert Wolk,Samuel H. Zwillich,Alexandre Lejeune

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY（2024）

引用0浏览0WOS引用

54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata

Brett King,Natasha A. Mesinkovska,Arash Mostaghimi,Colleen Hamilton,James Cassella

Journal of the American Academy of Dermatologyno. 3 (2024): AB281

引用0浏览0引用

Sustained Hair Regrowth with Continued Ritlecitinib Treatment Through Week 48 in Patients with Alopecia Areata with or Without Early Target Responses: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Trial

Melissa Piliang,Charles Lynde,Brett King, Paradi Mirmirani,Rodney Sinclair,Maryanne Senna,Seth Forman, Lindsey Bordone, Pablo De La Cueva Dobao,Robert Wolk,Samuel H Zwillich,Helen Tran,Dalia Wajsbrot, Haytham Mohamed Ahmed,Liza Takiya

Journal of the American Academy of Dermatology (2024)

引用0浏览0WOS引用

Continued Treatment with Baricitinib Results in Meaningful Scalp Responses among Scalp Non-Responder Patients with Eyebrow/eyelash Regrowth in the First Year

Arash Mostaghimi,Matthias Augustin, Kazutoshi Harada,Maryanne Senna, Yves Dutronc, Guanglei Yu, Susan Ball, Mwangi Murage, Jill Kolodsick, Yiying Brogan,Brett King

Journal of the European Academy of Dermatology and Venereology JEADV (2024)

引用0浏览0WOS引用

51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials

Maryanne Makredes Senna,Brett King,Natasha A. Mesinkovska,Arash Mostaghimi,Colleen Hamilton,James Cassella

Journal of the American Academy of Dermatologyno. 3 (2024): AB39

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

副教授

论文共 234 篇作者统计合作学者相似作者